Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
638
datasets available to search
ShareScore release 0.9.0
Dataset results
638 results for “erlotinib”
Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00696696. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Erlotinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00287989. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Tarceva (Erlotinib) in Combination With Avastin (Bevacizumab) in Patients With Advanced Non-Small Cell Lung Cancer.
ClinicalTrials.gov study NCT00531960. IPD Sharing: Not stated. Countries: 13. Publications: 1.
Erlotinib in Treating Patients With Recurrent or Metastatic Skin Squamous Cell Carcinoma
ClinicalTrials.gov study NCT01198028. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Randomized Trial Of PF-00299804 Taken Orally Versus Erlotinib Taken Orally For Treatment Of Advanced Non-Small Cell Lung Cancer That Has Progressed After One Or Two Prior Chemotherapy Regimen
ClinicalTrials.gov study NCT00769067. IPD Sharing: Not stated. Countries: 12. Publications: 1.
A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone
ClinicalTrials.gov study NCT00265317. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With
ClinicalTrials.gov study NCT01013649. IPD Sharing: Not stated. Countries: 4. Publications: 3.
LUX-Lung 5: Afatinib Plus Weekly Paclitaxel Versus Investigator's Choice of Single Agent Chemotherapy Following Afatinib Monotherapy in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitin
ClinicalTrials.gov study NCT01085136. IPD Sharing: Not stated. Countries: 23. Publications: 1.
Single Agent Erlotinib in Chemotherapy-naive Androgen Independent Prostate Cancer
ClinicalTrials.gov study NCT00272038. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme
ClinicalTrials.gov study NCT00672243. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Erlotinib and Docetaxel in Second Line of Treatment in Patients With Non Small Cell Lung Cancer
ClinicalTrials.gov study NCT01350817. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)
ClinicalTrials.gov study NCT00671970. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib
ClinicalTrials.gov study NCT00548093. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations
ClinicalTrials.gov study NCT02588261. IPD Sharing: YES. Countries: 23. Publications: 1.
A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY)
ClinicalTrials.gov study NCT02411448. IPD Sharing: YES. Countries: 14. Publications: 13.
A Study of Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00883779. IPD Sharing: Not stated. Countries: 7. Publications: 1.
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer
ClinicalTrials.gov study NCT00452413. IPD Sharing: Not stated. Countries: 1. Publications: 1.
BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC)
ClinicalTrials.gov study NCT01562028. IPD Sharing: Not stated. Countries: 8. Publications: 4.
Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar
ClinicalTrials.gov study NCT00476476. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib
ClinicalTrials.gov study NCT00609804. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.